Evaluation of the stability of aciclovir in elastomeric infusion devices used for outpatient parenteral antimicrobial therapy

Fekade Bruck Sime, Steven Wallis, Conor Jamieson, Tim Hills, Mark Gilchrist, Mark Santillo, R Andrew Seaton, Felicity Drummond, Jason Roberts
{"title":"Evaluation of the stability of aciclovir in elastomeric infusion devices used for outpatient parenteral antimicrobial therapy","authors":"Fekade Bruck Sime, Steven Wallis, Conor Jamieson, Tim Hills, Mark Gilchrist, Mark Santillo, R Andrew Seaton, Felicity Drummond, Jason Roberts","doi":"10.1136/ejhpharm-2023-003784","DOIUrl":null,"url":null,"abstract":"Objectives To investigate the stability of aciclovir solutions in elastomeric devices used for outpatient parenteral antimicrobial therapy (OPAT). Methods Triplicates of two elastomeric devices, Accufuser and Easypump II, were filled with a solution of 200 mg, 2400 mg, and 4500 mg aciclovir in 240 mL 0.9% w/v saline. Devices were stored at room temperature for 14 days, followed by 24 hours storage at 32°C. Assessment using a stability indicating assay, pH and subvisible particle analysis was undertaken at 11 time points throughout the study. Results Aciclovir solution at 200 mg and 2400 mg in 240 mL was stable for 14 days at room temperature (<20°C) and 24 hours of 32°C ‘in-use’ temperature exposure, remaining above the 95% limit for NHS stability protocols. The high dose was also stable for 14 days at room temperature, but when stored at 32°C there was precipitation of aciclovir within 4 hours in both devices. The precipitate was confirmed as aciclovir and precipitation was not a sign of chemical degradation. Conclusions Aciclovir concentrations above 2400 mg/240 mL are liable to precipitation and cannot be recommended for OPAT services because of heightened risks of nephrotoxicity. Aciclovir solution can be given as a continuous 24-hour infusion for OPAT services at a concentration range of 200–2400 mg in 240 mL in Accufuser and Easypump II elastomeric devices following 14 days storage at room temperature, protected from light. All data relevant to the study are included in the article or uploaded as supplementary information.","PeriodicalId":11998,"journal":{"name":"European Journal of Hospital Pharmacy","volume":"221 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-12-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Hospital Pharmacy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/ejhpharm-2023-003784","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives To investigate the stability of aciclovir solutions in elastomeric devices used for outpatient parenteral antimicrobial therapy (OPAT). Methods Triplicates of two elastomeric devices, Accufuser and Easypump II, were filled with a solution of 200 mg, 2400 mg, and 4500 mg aciclovir in 240 mL 0.9% w/v saline. Devices were stored at room temperature for 14 days, followed by 24 hours storage at 32°C. Assessment using a stability indicating assay, pH and subvisible particle analysis was undertaken at 11 time points throughout the study. Results Aciclovir solution at 200 mg and 2400 mg in 240 mL was stable for 14 days at room temperature (<20°C) and 24 hours of 32°C ‘in-use’ temperature exposure, remaining above the 95% limit for NHS stability protocols. The high dose was also stable for 14 days at room temperature, but when stored at 32°C there was precipitation of aciclovir within 4 hours in both devices. The precipitate was confirmed as aciclovir and precipitation was not a sign of chemical degradation. Conclusions Aciclovir concentrations above 2400 mg/240 mL are liable to precipitation and cannot be recommended for OPAT services because of heightened risks of nephrotoxicity. Aciclovir solution can be given as a continuous 24-hour infusion for OPAT services at a concentration range of 200–2400 mg in 240 mL in Accufuser and Easypump II elastomeric devices following 14 days storage at room temperature, protected from light. All data relevant to the study are included in the article or uploaded as supplementary information.
评估阿昔洛韦在用于门诊肠外抗菌治疗的弹性输液器中的稳定性
目的 研究门诊肠外抗菌治疗 (OPAT) 弹性装置中阿昔洛韦溶液的稳定性。方法 用 240 毫升 0.9% w/v 生理盐水分别注入 200 毫克、2400 毫克和 4500 毫克阿昔洛韦溶液的三重样两种弹性装置(Accufuser 和 Easypump II)。设备在室温下存放 14 天,然后在 32°C 下存放 24 小时。在整个研究过程中的 11 个时间点使用稳定性指示测定、pH 值和亚可见颗粒分析进行评估。结果 200 毫克和 2400 毫克 240 毫升的阿昔洛韦溶液在室温(<20°C)和 32°C "使用中 "温度暴露 24 小时 14 天内保持稳定,仍高于 NHS 稳定性协议的 95% 限值。高剂量在室温下也稳定了 14 天,但在 32°C 下储存时,两种装置中的阿昔洛韦在 4 小时内均出现沉淀。经确认,沉淀物为阿昔洛韦,沉淀并非化学降解的迹象。结论 2400 毫克/240 毫升以上浓度的阿昔洛韦易发生沉淀,由于肾毒性风险增加,因此不建议用于 OPAT 服务。阿昔洛韦溶液在室温避光条件下储存 14 天后,可在 Accufuser 和 Easypump II 弹性装置中以 240 毫升中含 200-2400 毫克的浓度范围内 24 小时连续输注,用于 OPAT 服务。与该研究相关的所有数据均包含在文章中或作为补充信息上传。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信